Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.35 USD | +5.38% | -7.11% | -4.47% |
Mar. 27 | HC Wainwright Adjusts BioAtla's Price Target to $7 From $10, Maintains Buy Rating | MT |
Mar. 26 | Transcript : BioAtla, Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.47% | 113M | |
+4.09% | 43.84B | |
+9.45% | 41.68B | |
+46.06% | 41.25B | |
-10.92% | 27.04B | |
+9.32% | 25.53B | |
-24.87% | 18.18B | |
+1.28% | 12.29B | |
+29.70% | 12.29B | |
+7.78% | 11.15B |
- Stock Market
- Equities
- BCAB Stock
- News BioAtla, Inc.
- BioAtla : JPMorgan Adjusts BioAtla's Price Target to $64 from $62, Keeps Overweight Rating